World Heart acquires Novacor to pursue heart assist market
This article was originally published in Clinica
Executive Summary
Canadian company World Heart has become the owner of the Novacor ventricular assist device (VAD) division of Edwards Lifesciences, in a deal which gives World Heart access to a proprietary material that should accelerate the approval of its long-term fully implantable HeartSaverVAD.